Harvard Obtains Manufacturing and Selling Rights and Cellectis Receives Upfront and Milestones Fees While Retaining Certain Rights

CORRECTING Dates in Exhibits 3 & 4: HBIO Reports Third Quarter Results HOLLISTON, Mass., Nov 03, 2005 (BUSINESS WIRE) -- In exhibit 3, column header for last three columns should read: Three months ended September 30, 2004 (sted 2005) and in exhibit 4, column header for last three columns should

Dr. Susan Zusman, Former Executive Director of Functional Genomics at Novartis, Joins Harvard Bioscience as VP R&D of its Union Biometrica Subsidiary HOLLISTON, Mass., Oct 8, 2001 /PRNewswire via COMTEX/ -- Today Harvard Bioscience, Inc. (Nasdaq: HBIO) announced that Dr.

Transplant Patient Enjoys Good Quality of Life With No Complications

Forum Alert: Harvard Bioscience Inc. Presentation at Informed Investors Biotechnology & Pharmaceuticals Stocks Forum at the Princeton Club in NYC on Wednesday, June 23, 2004, 11:30 am ET HOLLISTON, Mass., June 21 /PRNewswire/ -- David Green, President of Harvard Bioscience Inc.

Genomic Solutions -a Harvard Bioscience company- and Bruker Daltonics Sign Value Added Reseller Agreement HOLLISTON, Mass., Jan 7, 2003 (BUSINESS WIRE) -- Genomic Solutions, a subsidiary of Harvard Bioscience, Inc. (NASDAQ: HBIO), and Bruker Daltonics, Inc.

Genomic Solutions Inc., a Harvard Bioscience Company, Completes Acquisition of GeneMachines HOLLISTON, Mass., Mar 12, 2003 (BUSINESS WIRE) -- Genomic Solutions, Inc., a wholly-owned subsidiary of Harvard Bioscience, Inc. (NASDAQ: HBIO), announced today the acquisition of substantially all of the

Genomic Solutions, a Harvard Bioscience Company, to Acquire GeneMachines HOLLISTON, Mass., Mar 3, 2003 (BUSINESS WIRE) -- Genomic Solutions, Inc., a wholly-owned subsidiary of Harvard Bioscience, Inc. (NASDAQ: HBIO), announced today the signing of a definitive agreement to purchase substantially

Harvard Apparatus And Trega Biosciences Announce Harvard's Acquisition Of The Diffusion Chamber Systems Product Line From Trega Biosciences San Diego, CA and Holliston, MA -- December 3rd, 1999 -- Trega Biosciences, Inc (NASDAQ:TRGA) of San Diego, CA, and Harvard Apparatus, Inc.

Harvard Apparatus Completes The Aquisition Of Amika Corporation Harvard Apparatus Inc. (HAI) of Holliston, MA, announced today that it has completed the acquisition of substantially all the assets of AmiKa Corp., whose products are at the heart of much of today's gene and protein discovery.